Private Capital Management (Minnesota)’s Biogen BIIB Stock Holding History

Private Capital Management (Minnesota)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$313K	Sell	1,000 -900	-47%	-$267K	0.35%	129
2017 Q2	$516K	Buy	1,900 +600	+46%	+$159K	0.57%	74
2017 Q1	$355K	Buy	1,300 +300	+30%	+$84.8K	0.39%	110
2016 Q4	$284K	Sell	1,000 -450	-31%	-$133K	0.32%	129
2016 Q3	$454K	Sell	1,450 -1,050	-42%	-$311K	0.48%	89
2016 Q2	$605K	Buy	2,500 +175	+8%	+$46.1K	0.6%	62
2016 Q1	$605K	Buy	2,325 +150	+7%	+$39.6K	0.56%	75
2015 Q4	$666K	Buy	+2,175	New	+$625K	0.61%	56

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Private Capital Management (Minnesota)'s BIIB Position: Q3 2017 in Review

Private Capital Management (Minnesota) reduced its Biogen (BIIB) stake by 47% in Q3 2017, selling an estimated $267K and leaving 1,000 shares worth $313K. The position accounts for 0.35% of the portfolio, ranked #129.

Private Capital Management (Minnesota) first reported a position in BIIB in Q4 2015 and has held it in 8 quarters since. The position peaked at $666K in Q4 2015. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

Private Capital Management (Minnesota) held 1,000 shares of Biogen worth $313K as of Q3 2017.
Private Capital Management (Minnesota) sold 900 Biogen shares in Q3 2017, an estimated $267K.
Biogen made up 0.35% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #129 holding.
Private Capital Management (Minnesota) first reported a position in Biogen in Q4 2015 and has held it in 8 quarters since.
Private Capital Management (Minnesota)'s Biogen position peaked at $666K in Q4 2015.
1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.